Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-19 3:6:12 pm | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA | PRNewsWire |
| 2024-03-18 8:23:0 am | Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up | Zacks |
| 2024-03-18 3:55:0 am | J&J (JNJ) Gets FDA Panel Vote for Carvykti's Expanded Use | Zacks |
| 2024-03-13 6:54:0 am | Pfizer's (PFE) Adcetris Meets Survival Goal in Lymphoma Study | Zacks |
| 2024-03-08 7:46:0 am | MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag | Zacks |
| 2024-03-07 7:47:0 am | Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia | Zacks |
| 2024-03-06 8:55:31 pm | Chairman of Vanda Pharmaceuticals Inc (VNDA) Sells Shares | GuruFocus.com |
| 2024-03-06 9:33:0 am | Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata | Zacks |
| 2024-03-06 4:0:0 am | Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia | PR Newswire |
Please consider a small donation if you think this website provides you with relevant information